786 related articles for article (PubMed ID: 29896673)
21. Regulation of KSHV Latency and Lytic Reactivation.
Broussard G; Damania B
Viruses; 2020 Sep; 12(9):. PubMed ID: 32957532
[TBL] [Abstract][Full Text] [Related]
22. The Kaposi' s sarcoma-associated herpesvirus latency-associated nuclear antigen.
Komatsu T; Barbera AJ; Ballestas ME; Kaye KM
Viral Immunol; 2001; 14(4):311-7. PubMed ID: 11792061
[TBL] [Abstract][Full Text] [Related]
23. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.
Cotter MA; Robertson ES
Virology; 1999 Nov; 264(2):254-64. PubMed ID: 10562490
[TBL] [Abstract][Full Text] [Related]
24. Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis.
Sun Z; Jha HC; Robertson ES
J Virol; 2015 Oct; 89(20):10206-18. PubMed ID: 26223641
[TBL] [Abstract][Full Text] [Related]
25. Human herpesvirus 8-encoded proteins with potential roles in virus-associated neoplasia.
Nicholas J
Front Biosci; 2007 Jan; 12():265-81. PubMed ID: 17127298
[TBL] [Abstract][Full Text] [Related]
26. Kaposi's sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters.
Izumiya Y; Algalil A; Espera JM; Miura H; Izumiya C; Inagaki T; Kumar A
J Virol; 2024 Feb; 98(2):e0138623. PubMed ID: 38240593
[TBL] [Abstract][Full Text] [Related]
27. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.
Cathomas G
Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339
[TBL] [Abstract][Full Text] [Related]
28. Recent Advances in Developing Treatments of Kaposi's Sarcoma Herpesvirus-Related Diseases.
Naimo E; Zischke J; Schulz TF
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578378
[TBL] [Abstract][Full Text] [Related]
29. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201
[TBL] [Abstract][Full Text] [Related]
30. Signal Transduction Pathways Associated with KSHV-Related Tumors.
Watanabe T; Sugimoto A; Hosokawa K; Fujimuro M
Adv Exp Med Biol; 2018; 1045():321-355. PubMed ID: 29896674
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus.
Bigi R; Landis JT; An H; Caro-Vegas C; Raab-Traub N; Dittmer DP
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11379-E11387. PubMed ID: 30429324
[TBL] [Abstract][Full Text] [Related]
32. miRNAs and their roles in KSHV pathogenesis.
Hussein HAM; Alfhili MA; Pakala P; Simon S; Hussain J; McCubrey JA; Akula SM
Virus Res; 2019 Jun; 266():15-24. PubMed ID: 30951791
[TBL] [Abstract][Full Text] [Related]
33. Single molecule analysis of replicated DNA reveals the usage of multiple KSHV genome regions for latent replication.
Verma SC; Lu J; Cai Q; Kosiyatrakul S; McDowell ME; Schildkraut CL; Robertson ES
PLoS Pathog; 2011 Nov; 7(11):e1002365. PubMed ID: 22072974
[TBL] [Abstract][Full Text] [Related]
34. Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses.
Davis DA; Naiman NE; Wang V; Shrestha P; Haque M; Hu D; Anagho HA; Carey RF; Davidoff KS; Yarchoan R
PLoS Pathog; 2015 Jul; 11(7):e1005064. PubMed ID: 26218605
[TBL] [Abstract][Full Text] [Related]
35. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma.
Dupin N; Fisher C; Kellam P; Ariad S; Tulliez M; Franck N; van Marck E; Salmon D; Gorin I; Escande JP; Weiss RA; Alitalo K; Boshoff C
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4546-51. PubMed ID: 10200299
[TBL] [Abstract][Full Text] [Related]
36. NDRG1 facilitates the replication and persistence of Kaposi's sarcoma-associated herpesvirus by interacting with the DNA polymerase clamp PCNA.
Zhang F; Liang D; Lin X; Zou Z; Sun R; Wang X; Liang X; Kaye KM; Lan K
PLoS Pathog; 2019 Feb; 15(2):e1007628. PubMed ID: 30811506
[TBL] [Abstract][Full Text] [Related]
37. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with human myeloid cell nuclear differentiation antigen induced by interferon alpha.
Fukushi M; Higuchi M; Oie M; Tetsuka T; Kasolo F; Ichiyama K; Yamamoto N; Katano H; Sata T; Fujii M
Virus Genes; 2003 Dec; 27(3):237-47. PubMed ID: 14618084
[TBL] [Abstract][Full Text] [Related]
38. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
Viejo-Borbolla A; Schulz TF
AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
[TBL] [Abstract][Full Text] [Related]
39. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y
Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388
[TBL] [Abstract][Full Text] [Related]
40. Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice.
Jeong JH; Hines-Boykin R; Ash JD; Dittmer DP
J Virol; 2002 Nov; 76(21):11024-32. PubMed ID: 12368345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
